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Recent studies have shown that the incidence of
syncope in emergency departments is 0.9–1.7%
of all attendances. One-third of these patients are
diagnosed with unexplained syncope despite com-
plete medical check-up, and several non-invasive
and invasive examinations.1–5) An implantable loop
recorder (ILR) has a loop memory, which continu-
ously records the electrical activity of the heart
(Figure 1). When the ILR is activated by a patient
with symptoms of syncope, the electrical activity of
the heart several minutes before activation is stored
and can be retrieved for analysis. ILR is a promising
technology for elucidating the cause of syncope in
patients with unexplained syncope.
Case report
A 70-year-old man with syncope was referred to
our hospital. He had total loss of consciousness 3
times in the past 3 years and had suﬀered from a
head injury the last time he was unconsciousness.
The results of a physical examination and other tests
including 12-lead ECG, Holter ECG, echocardiog-
raphy, exercise stress test, carotid sinus massage and
head-up tilt testing, were not indicative of the cause
of syncope. With the patient’s consent, we decided
to implant an ILR. Three months after ILR implan-
tation, the patient had total loss of consciousness
while he was playing golf. ILR recordings showed
a transient complete atrioventricular block and 17
seconds of ventricular arrest (Figure 2). The patient
underwent electrophysiological study with sodium
channel blocker test to induce blockade of the
specialized conduction system, and coronary angiog-
raphy with acetylcholine stress test to induce vaso-
spasm. No signiﬁcant ﬁndings were obtained. Final-
ly, a permanent pacemaker was implanted, and
thereafter he did not have syncope.
An ILR is a small device that continuously
monitors heart rhythms and records them automati-
cally or when the patient uses a hand-held activator.
The device is implanted beneath the skin in the upper
chest under local anesthesia (Figure 3) and has a
battery life of up to 36 months. ILRs continuously
record the electrical activity of the heart. If the
recording suggests a heart-related cause of syncope,
an appropriate therapy may be selected on the basis
of the cause. When the possibility of arrhythmia can
be ruled out, the treatment strategy may be based on
other potential causes. The disadvantages associated
with the use of ILRs include the need for a minor
surgical procedure, the fact that sometimes it can
be diﬃcult to diﬀerentiate between supraventric-
ular and ventricular arrhythmias, and the presence
of under- or oversensing that may ﬁll the memory.
The gold standard for the diagnosis of syncope
associated with arrhythmia is when a correlation
between the symptom and a documented arrhyth-
mia is recorded. Although the absence of a
recording of arrhythmia during syncope cannot
be considered a speciﬁc diagnosis, it allows the
exclusion of arrhythmia as the cause of the
syncope. The prognosis of cardiogenic syncope is
worse than that of syncope due to other cause.6) In
addition, cardiogenic syncope may be an indicator
of sudden cardiac death. ILRs may assist in theFigure 1 Reveal DX, Assistant (activator), and Programmer.
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identiﬁcation of patients with cardio-
genic syncope.
Insurance reimbursement for ILR
implantation has been granted in
Japan since October, 2009. The
number of implantations of ILR is
increasing gradually every year. The
ESC guidelines for the diagnosis and
management of syncope,7) indicate
that ILRs should be implanted dur-
ing the early phase of evaluation in
patients with recurrent syncope of
uncertain origin and absence of
high risk criteria (Class I, evidence
level B), the guidelines also indicate
implantation in high-risk patients in
whom comprehensive evaluation did
not indicate the cause of syncope or
a speciﬁc treatment strategy (Class I,
evidence level B). Initially, ILRs
were used for diagnosis in patients
with unexplained syncope at the end
of a completely negative work-up.
Recently, however, it is believed the
early use of ILRs may be more cost-
eﬀective than conventional investi-
gation strategies.
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Figure 2 Transient complete atrioventricular block when the patient had total
loss of consciousness.
Figure 3 Chest radiograph. Reveal implanted near the heart.
Reveal is implanted under the skin at the site where more than
1mV R wave of ECG may be recorded.
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